Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07535814) titled 'Aldosterone Identifies a High-Risk Recurrent Phenotype in Severe Hypertension' on April 5.

Study Type: Observational [Patient Registry]

Primary Sponsor: School of Medicine. National University of Cuyo

Condition: Acute Severe Hypertension

Recruitment Status: Not recruiting

Date of First Enrollment: March 1, 2022

Target Sample Size: 500

Countries of Recruitment: Argentina

To know more, visit https://clinicaltrials.gov/study/NCT07535814

Published by HT Digital Content Services with permission from Health Daily Digest....